title: View and present status of personnel involved in clinical trials: a survey of participants from the First Symposium of the Shikoku Collaborative Group for Promotion of Clinical Trials.
abstract: Clinical trials leading to drug approval (registration trials) play a central role in the drug development process. Since the introduction of the Good Clinical Practice (GCP) standard in 1997, the Japanese infrastructure for registration trials has improved. The contribution of support staff, including clinical research coordinators (CRCs), to clinical trials is now widely recognized in Japan. Quality issues and career development for these support staff are being increasingly emphasized. The Shikoku Collaborative Group for Promotion of Clinical Trials was organized in 2008 to address these issues through communication with the personnel involved in clinical trials in regional areas of Japan. To understand the views and present status of personnel involved in clinical trials, we used questionnaires to survey the participants of the First Symposium of the Shikoku Collaborative Group for Promotion of Clinical Trials held in August 2009. Group discussions and special lectures occurred at the symposium. The questionnaire began with questions about basic patient characteristics, followed by practical questions. Of 110 participants, there were 68 respondents (62%), including clinical trial support staff (clinical research coordinators [n=36, 53%], administrative officers [n=9, 13%]), and medical staff [n=23, 34%]). Among the support staff, 36 (80%) had more than 5 years of experience. The most common questionnaire answer selected for participation in the symposium was "willing to contact staff from other medical institutions or organizations" for support staff and "to obtain further knowledge concerning clinical trials" for medical staff. The overall view of the discussion ("Was the discussion satisfactory?") was favorable for 36 (53%) respondents. This survey revealed that the group discussion in the present symposium appears to be valuable for participants, using overall satisfaction as a surrogate. Based on the information obtained in the present study, further development of the clinical trial infrastructure, including training opportunities and career development for support staff, is required. Due to the limitations of this study, further analysis is warranted to determine the optimal strategy for training support staff.
authors.affiliation: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Yanagawa
authors.forename: Minoru
authors.initials: M
authors.lastname: Irahara
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Houchi
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Kakehi
authors.forename: Takashi
authors.initials: T
authors.lastname: Moritoyo
authors.forename: Masahiro
authors.initials: M
authors.lastname: Nomoto
authors.forename: Mitsuhiko
authors.initials: M
authors.lastname: Miyamura
authors.forename: Taro
authors.initials: T
authors.lastname: Shuin
mesh_terms: D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000592:standards; D003299:Cooperative Behavior; D017277:Drug Approval; D055808:Drug Discovery; D006282:Health Personnel / Q000193:education; D006801:Humans; D007564:Japan; D011795:Surveys and Questionnaires; D000078329:Workforce